Montu
SaaS platform matching creators, orchestrating campaigns
Clinical Pharmacist
Three days on-site and two days working remotely; evening and weekend on-site work is required.
About the job
- Be a General Pharmaceutical Council-registered pharmacist with an Independent Prescriber qualification.
- Have at least 2 years of prescribing experience.
- Have experience working in a clinical setting.
- Communicate clearly and confidently across clinical and non-clinical settings.
- Manage time effectively and prioritise competing demands.
- Be proactive and resourceful when identifying and resolving problems.
- Be well-organised, detail-oriented, and able to manage complex workflows.
- Clinically check and review cannabis-based medicine prescriptions for safety and accuracy.
- Prescribe medicines as an Independent Prescriber, tailoring treatments to individual patient needs.
- Provide expert guidance to prescribers and patients on treatment options.
- Maintain accurate patient records in line with General Pharmaceutical Council standards.
- Support the dispensary team by handling complex clinical queries.
- Deliver education and training on cannabis-based medicines to patients, clinicians, and staff.
- Collaborate with the wider team to streamline processes and improve outcomes.
- Knowledge of cannabis-based medicines is desired but not essential, or willingness to undergo specialised training.
About the company
Montu is a Latin American SaaS that helps brands scale UGC ads, Reels, TikTok, and marketplace clips by connecting them with a verified creator network and managing campaigns end to end. It functions as infrastructure: brands publish briefs and budgets, creators apply with Instagram/TikTok metrics, and Montu handles matching, production coordination, unlimited revisions, approvals, and payments, delivering a single invoice. It differentiates itself by offering a scalable, creator-centric platform with tens of thousands of verified creators and brand-level governance across multiple campaigns, rather than acting as a full-service agency. The goal is to give LatAm brands a reliable, scalable way to run creator-driven campaigns with streamlined workflow and payments, enabling growth through UGC across social platforms.
Company Size
1-10
Company Stage
Early VC
Total Funding
$3.6M
Headquarters
Santiago, Chile
Founded
2019
Get referred to Montu
See people who can refer or advise you
Simplify's Take
What believers are saying
- Montu’s site claimed 27,000 active creators and campaigns across Meta and TikTok on 2026-09-22.
- The app store listing said 35,000 creators and verified brands in four countries on 2026-09-11.
- Pricing tiers from $59,990 to enterprise suggest clear monetization and upgrade paths.
What critics are saying
- LinkedIn shows only 1-10 employees, limiting sales capacity and support coverage.
- Montu discloses no funding or major enterprise customers, so distribution remains unproven.
- Meta and TikTok can absorb creator matching and payments, commoditizing Montu’s core workflow.
What makes Montu unique
- Montu packages UGC sourcing, approvals, and creator payouts into one SaaS workflow.
- It focuses on Latin American brands, with Spanish-language support and local payment rails.
- The platform combines verified creator profiles, campaign briefs, and unlimited revision management.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Paid Vacation
401(k) Company Match
401(k) Retirement Plan
Cycle to work scheme
Company News
Montu has named former Pharmacy Guild of Australia national president George Tambassis as a special adviser.
Montu is launching online clinic Alternaleaf in the UK, headed up by local managing director Asif Dewan.
Montu has joined forces with Chronic Pain Australia (CPA) to promote Pain Awareness Month in a bid to raise A$100,000 for the cause.
We are Montu. Our mission: Improve lives for millions of Australians through medical cannabis therapies.
Montu will use the funds to boost its marketing and attract more doctors on to the platform to service patients who need cannabidiol-related treatments.